Science
New MS Treatment Research
Scientists suggest that antivirals targeting Epstein-Barr viruses could be a promising treatment for multiple sclerosis, potentially reducing side effects.
Coverage timeline — 1 article
New Scientist
Low levels of replicating Epstein-Barr viruses might be the main driver of the autoimmune condition multiple sclerosis. This may mean that targeting them would be as effective as suppressing the immune system, with fewer side effects
2026-07-15 18:00 UTC